Komori
Other Disclosures4891TMS Co.,Ltd.Pharmaceuticals

Company Chairman of the Board Hasumi Keiji (蓮見惠司) to Appear on NHK WORLD JAPAN’s “Medical Frontiers”

The Company announced that its Chairman of the Board, Hasumi Keiji (蓮見惠司), will appear on an NHK WORLD JAPAN medical program and explain the Company’s SMTP compounds and products under development. The program will be livestreamed from 23 November 2026 and made available on demand after broadcast.

Worth reading
41Recurring
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

SMTP compound familyTMS-007(JX10)TMS-008
Applicable field (uses covered by this announcement)

Acute ischemic stroke treatment; medical care and pharmaceutical development

Launch date23 November 2026 (scheduled; start of live streaming). Available on demand after broadcast.
Relationship between the counterparty and the company
TMS Co.,Ltd.4891
Relationship with the Company

The Company’s Chairman of the Board, Hasumi Keiji (蓮見惠司), will appear on the program and explain the SMTP compounds.

CounterpartyNHK WORLD JAPAN「Medical Frontiers」

A program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredSMTP compound family, TMS-007(JX10), TMS-008
CounterpartyNHK WORLD JAPAN「Medical Frontiers」
Counterparty overviewA program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide.
Relationship with the CompanyThe Company’s Chairman of the Board, Hasumi Keiji (蓮見惠司), will appear on the program and explain the SMTP compounds.
Launch date23 November 2026 (scheduled; start of live streaming). Available on demand after broadcast.
Applicable areaAcute ischemic stroke treatment; medical care and pharmaceutical development
Items this document does not state (12)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because NHK WORLD JAPAN’s “Medical Frontiers” is a program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Company Chairman of the Board Hasumi Keiji (蓮見惠司) to Appear on NHK WORLD JAPAN’s “Medical Frontiers” | TMS Co.,Ltd. (4891) timely disclosure | Komori